FDA Approves Opdivo and Yervoy Combination for Advanced Melanoma
September 30, 2015Statement from Tim Turnham, Executive Director, Melanoma Research Foundation The Melanoma Research Foundation (MRF) applauds the FDA’s approval of the combination of Opdivo (nivolumab) and Yervoy (ipilimumab) for patients with previ …
World Champion Athlete Joins Fight Against Melanoma
September 4, 2015Leanda Cave Partners with the Melanoma Research Foundation to Raise Awareness of the Deadliest Form of Skin Cancer WASHINGTON, D.C.— Four-time Triathlon World Champion and internationally-renowned endurance athlete Leanda Cave is joining f …
The MRF Urges Administration to Take Measures to Prevent Skin Cancer Deaths
September 1, 2015The Melanoma Research Foundation submitted a letter to the Office of Management and Budget (OMB) urging it to take the critical step toward reducing skin cancers. The Food and Drug Administration (FDA) has proposed a draft rule to tighten regulations o …
Guest Post: Why I Fight
August 28, 2015Guest blogger Frank Nichols shares his story as an ocular melanoma patient, advocate and participant in Miles for Melanoma NYC. My name is Frank Nichols and on August 29, I am walking in the Melanoma Research Foundation’s Miles for Melanoma 5k ru …
Melanoma Research Foundation Receives Highest Fiscal Responsibility Rating for 4th Consecutive Year
July 22, 2015Organization Remains Only Melanoma-Dedicated Nonprofit in the U.S. To Receive Ranking WASHINGTON, D.C.— The Melanoma Research Foundation’s (MRF) sound fiscal management practices and commitment to accountability and transparen …
Recent Comments